COVID-19Global NewsNews

Tata group in talks to launch Moderna COVID-19 vaccine in India: Report

Moderna’s vaccine can be stored at normal fridge temperatures

Tata Medical & Diagnostics could team up with India’s Council of Scientific and Industrial Research to carry out clinical trials of Moderna’s vaccine candidate in India, the report said

Tata Group’s healthcare venture is said to have started initial discussions with Moderna for a partnership to launch its COVID-19 vaccine in India.

Tata Medical & Diagnostics could team up with India’s Council of Scientific and Industrial Research to carry out clinical trials of Moderna’s vaccine candidate in India, citing officials familiar with the matter.

Moderna did not respond to Reuters request for comment outside business hours, while Tata Medical & Diagnostics did not immediately respond.

Unlike Pfizer’s vaccine, which must be kept at minus 70 degrees Celsius or below, Moderna’s can be stored at normal fridge temperatures, making it more suited for poorer countries such as India where cold chains are limited.

Data released in November from Moderna’s late-stage study showed it was 94.1 per cent effective with no serious safety concerns. The shot was approved for use in the US in December and Europe earlier this month.

India mandates that any vaccine maker must conduct an additional local study if it has to be considered for what the country calls the world’s biggest vaccination programme.

Reuters

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close